SIGA Technologies Inc.

8.13-0.31 (-3.67%)

Oct 29, 4:00:01 PM EDT · NasdaqGM · SIGA · USD

Upcoming Earnings

Report date

≈ Nov 6, 2025 (in 7 days)

Key Stats

Market Cap

582.16M

P/E (TTM)

7.13

Basic EPS (TTM)

1.14

Dividend Yield

Recent Filings

10-Q

8/5/25Aug 5, 2025

8-K

8/5/25Aug 5, 2025

8-K

6/12/25Jun 12, 2025

10-Q

5/8/25May 8, 2025

8-K

5/8/25May 8, 2025

About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

CEO

Dr. Diem Nguyen M.B.A., Ph.D.

IPO

9/10/1997

Website

https://www.siga.com

Employees

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic